Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at selumetinib for thyroid cancer that has stopped taking up radioactive iodine (SEL-I-METRY)

Overview

Cancer types:

Thyroid cancer

Status:

Closed

Phase:

Phase 2

Details

This trial is for people with thyroid cancer that has grown outside the thyroid (locally advanced) or spread to another part of the body (metastatic). It is for people with a type of thyroid cancer called differentiated thyroid cancer, which includes:

  • papillary thyroid cancer

  • follicular thyroid cancer

  • hürthle cell thyroid cancer

  • poorly differentiated thyroid cancer

Cancer Research UK supports this trial.

Recruitment start: 28 March 2017

Recruitment end: 15 August 2019

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Jonathan Wadsley

Supported by

Cancer Research UK

NIHR Clinical Research Network: Cancer

Sheffield Teaching Hospitals NHS Foundation Trust

University of Leeds

Butterfly Thyroid Cancer Trust

AstraZeneca

Sanofi-Genzyme

Other information

This is Cancer Research UK trial number CRUK/14/041.

Last reviewed: 13 April 2022

CRUK internal database number: 12867

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.